Clinical Trials
임상시험 트래커
국내사는 전체 임상 이력, 글로벌 메이저는 진행 중 파이프라인을 추적합니다. ClinicalTrials.gov API v2에서 6시간 주기로 수집합니다.
60 results (top 60)
- 3상모집 예정· Glabellar Lines일본인 대상 DWP450의 미간주름 치료 연구
Study of DWP450 in Japanese Subjects With Glabellar Lines
리드: 대웅제약
- 3상모집 예정· Gastric Ulcer위궤양 환자에서 DWP14012의 효과 및 안전성을 평가하는 3상 연구
Phase 3 to Evaluate the Efficacy and Safety of DWP14012 in Patients With Gastric Ulcer
리드: 대웅제약
- 3상모집 예정· Healed Erosive Esophagitis치유된 미란성 식도염 환자의 유지 치료를 위한 DWP14012의 유효성과 안전성을 평가하는 3상 임상시험 및 확대 연구
Efficacy and Safety of DWP14012 for Long-Term Maintenance Therapy in Patients With Healed Erosive Esophagitis
리드: 대웅제약
- 3상모집 예정· T2DM (Type 2 Diabetes Mellitus)제2형 당뇨병 환자에서 DWP16001 및 DWC202518 초기 병합 요법의 효능 및 안전성 평가
To Evaluate the Efficacy and Safety of Initial Combination Therapy With DWP16001 and DWC202518 Compared to DWP16001 Monotherapy and DWC202518 Monotherapy in Patients With Type 2 Diabetes Mellitus
리드: 대웅제약
- 1상모집 중· Obesity & Overweight건강한 성인 지원자에서 DWRX5003의 안전성과 DWC202502 및 DWC202503에 대한 상대 생체이용률을 평가하는 1상 임상시험
A Phase 1 Clinical Trial to Assess the Safety of DWRX5003 and Relative Bioavailability to DWC202502 and DWC202503 in Healthy Adult Volunteers
리드: 대웅제약
- 단계 미표기모집 예정· Peptic Ulcer실제 임상 진료에서 NSAID 유도 소화성 궤양 예방을 위한 펙수클루
Fexuclue for Prevention of NSAIDs-Induced Peptic Ulcer in Real-World Practice
리드: 대웅제약
- 단계 미표기모집 예정· Dyslipidemia이상지질혈증을 가진 한국인 환자에서 바로에젯 정제의 효능 및 안전성: 전향적 관찰 연구
Efficacy and Safety of Baroezet Tablet in Korean Patients With Dyslipidemia: A Prospective Observational Study
리드: 대웅제약
- 1상모집 중· CancerBRCA 변이 진행성 고등급 난소암 환자에서 DWZ2501의 동등성 연구
Bioequivalence Study of DWZ2501 in Patients With Advanced BRCA-mutated High-grade Ovarian Cancer
리드: 대웅제약
- 해당없음모집 예정· Respiratory Infection Virus실제 사용 환경에서 호흡기 감염 예방을 위한 Noseguard
Noseguard for Prevention of Respiratory Infections in Real-World Use
리드: 대웅제약
- 4상모집 예정· NSAID (Non-Steroidal Anti-Inflammatory Drug)NSAID 유발 소화성 궤양 예방에서 팩수프라잔의 효능 및 안전성 평가
Study to Evaluate the Efficacy and Safety of Fexuprazan in Prevention of NSAIDs Induced Peptic Ulcer
리드: 대웅제약
- 1상완료· Healthy SubjectsPK and Safety Comparison of DWJ445 and DWC202506 in Healthy Volunteers
리드: 대웅제약
- 해당없음모집 중· HypertensionCART BP Pro-Guided Blood Pressure Management for Uncontrolled Hypertension
협력: 대웅제약
- 단계 미표기모집 중· Stage 1 HypertensionObservational Study to Evaluate the Efficacy of OLMETEC Tab on Nocturnal Blood Pressure Control in Patients With Stage Ⅰ Hypertension
리드: 대웅제약
- 1상모집 중· Healthy SubjectsPK and Safety Comparison of DWJ1511 and DWC202501 in Healthy Volunteers
리드: 대웅제약
- 3상모집 예정· Glabellar LinesEvaluate the Efficacy and Safety of DWP712 With Moderate to Severe Glabellar Lines
리드: 대웅제약
- 해당없음모집 중단 (진행 중)· Functional DyspepsiaThe Effect of Two Prokinetics in Patients With Functional Dyspepsia
협력: 대웅제약
- 단계 미표기모집 중· GastritisEfficacy and Safety of FEXUCLUE Tab. In Patients With Acute or Chronic Gastritis
리드: 대웅제약
- 해당없음완료· Frailty in Older AdultsAllogeneic Human Mesenchymal Stem Cell Infusion for Frailty Patient
리드: 대웅제약
- 3상완료· Essential HypertensionA Phase III Study to Efficacy and Safety of DWC202405/DWC202313 and DWC202314 in Patients With Hypertension
리드: 대웅제약
- 4상모집 중· Obesity and Type 2 DiabetesEffects of Enavogliflozin on Coronary Microvascular and Cardiac Function in Obesity
협력: 대웅제약
- 3상완료· HypertensionEfficacy and Safety of DWC202404 and DWC202314 in Patients With Hypertension
리드: 대웅제약
- 4상모집 중· Aortic Valve StenosisENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement
협력: 대웅제약
- 단계 미표기모집 중· Diabetes Mellitus, Type 2Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or Dyslipidemia
리드: 대웅제약
- 해당없음모집 중· Type 2 DiabetesA Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH)
협력: 셀트리온, 종근당, 대웅제약
- 해당없음모집 중· Acute Coronary Syndromes (ACS)Fexuprazan for Prevention of Upper Gastrointestinal Bleeding in High Bleeding Risk Patients Receiving Dual Antiplatelet Therapy
협력: 대웅제약
- 해당없음완료· Arthroscopic SurgeryFunctional Outcomes After Hyaluronic Acid Injections Following Arthroscopy
리드: 대웅제약
- 1상모집 예정· Healthy VolunteersBioepuivalence Study for the Safety and the Pharmacokinetics of DWJ1589 and DWC202315
리드: 대웅제약
- 3상모집 예정· Type 2 Diabetic NephropathyEvaluate the Efficacy and Safety of DWP16001 in Type 2 Diabetic Nephropathy with Moderate Renal Impairment Patients
리드: 대웅제약
- 3상완료· Gastro Oesophageal Reflux DiseaseStudy Comparing Fexuprazan and Esomeprazole in Patients With Gastroesophageal Reflux Disease
협력: 대웅제약
- 1상상태 미확인· Erosive Gastroesophageal Reflux Diseaseto Evaluate the Safety/Tolerability and Pharmacokinetics, and Pharmacodynamics of DWP14012 Injection
리드: 대웅제약
- 단계 미표기모집 중단 (진행 중)· Type 2 Diabetes MellitusRegistry Study to Determine the Effectiveness and Safety of Weight Loss With Enavogliflozin in Patients With Type 2 Diabetes Mellitus
리드: 대웅제약
- 단계 미표기모집 중단 (진행 중)· Type 2 DiabetesEffect of Linking Data Using Smartphone Application, 'Well Check', on Clinical Outcomes in Patients With Type 2 Diabetes Mellitus
리드: 대웅제약
- 3상완료· Helicobacter Pylori InfectionStudy to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori
리드: 대웅제약
- 3상상태 미확인· T2DM (Type 2 Diabetes Mellitus)Study to Evaluate the Long Term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes Mellitus
리드: 대웅제약
- 1상완료· Glabellar LinesEvaluate the Safety and Explore the Efficacy of DWP712 With Moderate to Severe Glabellar Lines
리드: 대웅제약
- 1상상태 미확인· Healthy VolunteersBioequivalence Study for the Safety and the Pharmacokinetics of DWJ1568 in Healthy Adult Volunteers
리드: 대웅제약
- 1상상태 미확인· Healthy VolunteersBioequivalence Study for the Safety and the Pharmacokinetics of DWJ1567 in Healthy Adult Volunteers
리드: 대웅제약
- 1상상태 미확인· Drug Drug InteractionDrug-drug Interactions Between DWC202313 and DWC202314 in Healthy Subjects
리드: 대웅제약
- 3상모집 중단 (진행 중)· Tricuspid RegurgitationEnavogliflozin Outcome Trial in Functional Tricuspid Regurgitation
협력: 대웅제약
- 단계 미표기모집 중단 (진행 중)· Diabetes Mellitus, Type 2To Evaluate the Efficacy and Safety of Envlo Tablet or Envlomet SR Tablet in Patients With Type II Diabetes Mellitus
리드: 대웅제약
- 3상상태 미확인· Non-erosive Reflux DiseaseStudy to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-Erosive Gastroesophageal Reflux Disease (NERD)
리드: 대웅제약
- 2상상태 미확인· OsteoarthritisEfficacy of Probiotics for NSAID-induced Enteropathy in Arthritis Patients
협력: 대웅제약
- 1상상태 미확인· Healthy VolunteersBioequivalence Study for the Safety and the Pharmacokinetics of DWJ1558 in Healthy Adult Volunteers
리드: 대웅제약
- 1상상태 미확인· Healthy VolunteersBioequivalence Study for the Safety and the Pharmacokinetics of DWJ1543 in Healthy Adult Volunteers
리드: 대웅제약
- 1상상태 미확인· Healthy VolunteersBioequivalence Study for the Safety and the Pharmacokinetics of DWJ1543 With DWC202307 in Healthy Adult Volunteers
리드: 대웅제약
- 단계 미표기모집 중단 (진행 중)· DyslipidemiasA Study to Evaluate the Efficacy and Safety of CREZET Tablet
리드: 대웅제약
- 단계 미표기완료· Gastroesophageal Reflux DiseaseStudy to Evaluate the Efficacy and Safety of FEXUCLUE Tablet
리드: 대웅제약
- 1상상태 미확인· Diabetes Mellitus, Type 2To Compare the Safety and PK/PD Characteristics of Subjects With Between Hepatic Impairment and Normal Hepatic Function
리드: 대웅제약
- 4상모집 중· Coronary Artery DiseaseHarmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION)
협력: 대웅제약, 한미약품, 유한양행
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.